Purpose of Review: This review discusses movement disorders that occur during pregnancy, the treatment of preexisting movement disorders, and the influence the pregnant state has on movement disorders symptoms, in order to guide clinicians in providing better counseling for female patients who are pregnant or considering pregnancy.
Recent Findings: Unique considerations for movement disorders during pregnancy include investigations and their safety during pregnancy and the impact of treatment on both the pregnant patient and her fetus.
Summary: The most common movement disorders arising in pregnancy are restless leg syndrome and chorea gravidarum. Preexisting movement disorders in women who become pregnant may also be seen.
Address correspondence to Dr J. M. Miyasaki, 2E3.28 WMC, 8440 112th Street, Edmonton, Alberta, Canada T6G 2B7, firstname.lastname@example.org.
Relationship Disclosure: Dr Miyasaki has served as a speaker or on advisory boards for Novartis Corporation and Teva Pharmaceuticals. Dr Miyasaki has received research support from the Canadian Agency for Drugs and Technologies in Health, the Canadian Institute for Health Research, the Michael J. Fox Foundation for Parkinson’s Research, the National Center for Complementary and Alternative Medicine, the National Parkinson Foundation, the NIH, the Ontario Drug Benefits Program, and the Ontario Ministry of Health and Long-Term Care. The Movement Disorders Centre at Toronto Western Hospital has received research support from Teva Pharmaceuticals. Dr AlDakheel reports no disclosure.
Unlabeled Use of Products/Investigational Use Disclosure: Drs Miyasaki and AlDakheel report no disclosures.